An international multicenter prospective observational study including 6350 carriers of MMR gene variants showed that female MLH1, MSH2, and MSH6 carriers have a rapidly increasing risk of gynecological cancers from the age of 40 years. The gene discussed is MSH2; the disease is female reproductive organ cancer.